Leaflet CLEONITA 28 3mg / 0.02mg film-coated tablets
Indicated for: contraception
Route of administration: oral
Substance: drospirenone + ethinylestradiol (progestogen + estrogen)
ATC: G03AA12 (Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, fixed combinations)
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
The combination of Drospirenone + Ethinylestradiol is used as an oral contraceptive for the prevention of pregnancy and for the treatment of moderate acne in women seeking oral contraception. Drospirenone is a progestin, and Ethinylestradiol is a synthetic estrogen; together, they work to prevent ovulation and alter the uterine lining.
The medication is taken orally, usually once daily, according to a specific regimen. It is effective in preventing pregnancy and improving acne symptoms.
Side effects may include nausea, headache, weight changes, breast tenderness, and, in rare cases, thromboembolism. Regular monitoring is recommended during use.
Consult your doctor to discuss the benefits and risks of using this combination. Follow the administration instructions to ensure contraceptive effectiveness.
General data about CLEONITA 28 3mg / 0.02mg
- Substance: drospirenone + ethinylestradiol
- Date of latest medicines list: 01-10-2014
- Product code: W60793001
- Concentration: 3mg / 0.02mg
- Pharmaceutical form: film-coated tablets
- Quantity: 28
- Product type: Generic medicine
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Concentrations available for drospirenone + ethinylestradiol
- 3mg/0.02mg
- 3mg/0.030mg
- 3mg/0.03mg